BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 110860)

  • 1. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M; Imokawa G; Mishima Y
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y; Moro S; Seiji M
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
    Imokawa G; Mishima Y
    Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract]   [Full Text] [Related]  

  • 6. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K; Takeuchi T
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False dopa reaction in studies of mammalian tyrosinase: some characteristics and precautions.
    White R; Hu F; Roman NA
    Stain Technol; 1983 Jan; 58(1):13-9. PubMed ID: 6410541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GERL-coated vesicle system in the melanin synthesizing cell: its three-dimensional ultrastructure and tyrosinase activity (author's transl)].
    Ogura H; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(13):883-901. PubMed ID: 413959
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with elevated tyrosinase activity.
    Bomirski A; Wrzołkowa T; Arendarczyk M; Bomirska M; Kuklinska E; Słominski A; Moellmann G
    J Invest Dermatol; 1987 Nov; 89(5):469-73. PubMed ID: 3117904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
    Perrot H; Ortonne JP; Schmitt D
    Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
    Yamamoto H; Takeuchi T
    J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible processing of tyrosinase in the Golgi complexes of the melanocyte.
    Tomita Y; Hariu A; Kato C; Seiji M
    J Dermatol; 1985 Feb; 12(1):43-6. PubMed ID: 3926845
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular localization of tyrosinase in human malignant melanoma cell lines.
    Foa C; Aubert C
    J Invest Dermatol; 1977 Jun; 68(6):369-78. PubMed ID: 405430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of tyrosinase isoenzymes from hamster melanoma.
    Pomerantz SH; Li JP
    Yale J Biol Med; 1973 Dec; 46(5):541-52. PubMed ID: 4205121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
    Kageshita T; Ono T; Arao T; Tomita Y
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
    Akutsu Y; Jimbow K
    J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified method for the isolation of melanosomes from B16 melanoma.
    Haberman HF; Menon IA
    J Invest Dermatol; 1973 Feb; 60(2):67-72. PubMed ID: 4348133
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
    Seiji M; Moro S; Tomita Y
    Tohoku J Exp Med; 1978 Sep; 126(1):63-70. PubMed ID: 100898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.